W. Andrew Adams's most recent trade in National Health Investors, Inc. was a trade of 12,635 Common Stock by JMA Grandchildrens Trust done . Disclosure was reported to the exchange on Sept. 27, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Health Investors,... | W. Andrew Adams | Director | Other type of transaction at price $ 0.00 per share. | 27 Sep 2024 | 12,635 | 0 (0%) | 0% | 0 | Common Stock by JMA Grandchildrens Trust | |
| National Health Investors,... | W. Andrew Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | W. Andrew Adams | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2023 | 35,000 | 0 (0%) | 0% | 0 | Common Stock By Amk, L.p. | |
| National Health Investors,... | W. Andrew Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | W. Andrew Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | W. Andrew Adams | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jul 2021 | 45,307 | 177,000 (0%) | 0% | - | Common Stock By Adams Family Foundation II | |
| National Health Investors,... | W. Andrew Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 25,000 | 25,000 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | W. Andrew Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.52 per share. | 22 Feb 2021 | 20,000 | 36,513 (0%) | 0% | 60.5 | 1,210,400 | Common Stock |
| National Health Investors,... | W. Andrew Adams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 20,000 | 0 | - | - | Stock Options (Right to Buy) | |
| National Health Investors,... | W. Andrew Adams | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.79 per share. | 22 Feb 2021 | 17,344 | 19,169 (0%) | 0% | 69.8 | 1,210,438 | Common Stock |